Viral factors influencing the response to the combination therapy of peginterferon plus ribavirin in chronic hepatitis C
β Scribed by Shinya Maekawa; Nobuyuki Enomoto
- Book ID
- 106180552
- Publisher
- Springer Japan
- Year
- 2009
- Tongue
- English
- Weight
- 200 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We read with great interest the article published in a recent issue of HEPATOLOGY. 1 Shirakawa et al. enrolled 120 patients with chronic hepatitis C (CHC) infected with genotype 1 hepatitis C virus (HCV-1) and high baseline viral loads (HVL), defined by HCV RNA levels Υ 10 5 international units (IU)
## Abstract For chronic hepatitis C virus (HCV) infection, evaluation of response to peginterferon (PEGβIFN) plus ribavirin (RBV) therapy based on viral kinetics is useful as an early predictor of treatment efficacy, but the underlying mechanisms of the different viral kinetics to treatment are sti